Question 1

Has Tsewang Tashi, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $6,651,760 in general payments to Tsewang Tashi, MD across 455 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Tsewang Tashi, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Tsewang Tashi, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Blueprint Medicines Corporation	212	$3,838,939
Pharmaessentia USA Corporation	100	$1,292,913
Sanofi US Services Inc.	69	$773,274
AbbVie	36	$687,449
Incyte Corporation	33	$55,826
CTI Biopharma Corp.	1	$1,725
Pharmacyclics LLC, An Abbvie Company	2	$1,448
Jazz Pharmaceuticals Inc.	1	$119
Johnson & Johnson	1	$66

Tsewang Tashi, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other hematology & oncology in Salt Lake City